Taiko Pharmaceutical Co Ltd
TSE:4574
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Taiko Pharmaceutical Co Ltd (4574) under the Base Case is 199.69 JPY per share.
Compared with the current market price of 258 JPY, the stock appears
Overvalued by 23% .
The intrinsic value is calculated using the DCF method. The model assumes revenue returns to growth: about 2% a year over the next five years, after falling about 18% a year over the last five years. If revenue grew at its five-year pace of -18%, the estimate would be about ¥71.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Taiko Pharmaceutical Does
Taiko Pharmaceutical Co Ltd makes and sells medicines and health-related products in Japan. Its business is built around over-the-counter drugs, prescription-related items, and other products such as topical treatments and health foods. The company earns money by selling these products through pharmacies, drugstores, medical channels, and other retail and wholesale routes.
- Headquarters
- Japan JP
- Employees
- 220
- IPO date
- Mar 18, 2009
Revenue & Expenses Breakdown
Taiko Pharmaceutical Co Ltd
Earnings Waterfall
Taiko Pharmaceutical Co Ltd
Continue Research
Decided on Taiko Pharmaceutical? Get an email when Taiko Pharmaceutical Co Ltd reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Taiko Pharmaceutical Co Ltd stock?
The intrinsic value for
Taiko Pharmaceutical Co Ltd (4574) under the Base Case is 199.69 JPY.
Is Taiko Pharmaceutical Co Ltd stock undervalued or overvalued?
Compared with the current market price of 258 JPY, the stock appears Overvalued by 23% .